In 2009,a new round of medical reform kicked off,and since then,the"Healthy China"strategy and the"Healthy China 2030"Plan have been promulgated successively,marking the continuous advancement of the process of China's medical and health system reform.As the medical reform continues to release the momentum of reform,aiming at the problems of the drug supervision system,drug circulation management,and management system and op-eration mechanism of medical and health institutions,it continuously updates and improves drug management policies and regulations,changes the drug circulation and payment methods,expands the list of drugs under medical insur-ance,strengthens the drug supervision capacity,standardizes the drug circulation market,and promotes the rationaliza-tion of drug prices.So that people can actually feel the changes brought about by health reform.While breakthroughs have been made in medicine and healthcare reform,there is still room for improvement.At present,there are still problems in the holder system of drug marketing authorization,drug circulation and medical insurance collection.In response to the above problems,the corresponding reform suggestions were put forward to promote the innovation and development of the pharmaceutical management system by improving the supporting supervision of the drug marketing authorization holder system and the coordination between the two-vote system and the collection system,and ratio-nally adjusting the catalogue of the collection of medical insurance.At the same time,we should strengthen the infor-mation construction to explore more efficient drug management and more scientific drug reform direction,and promote our country from a pharmaceutical power to a pharmaceutical power.
Pharmaceutical administrationHealth care reformDrug policyCentralized procurement of drugsDrug marketing authorization holder system
NETL
NSTL
万方数据
